Forbes April 4, 2025
Joshua P. Cohen

It’s been rumored for quite some time that Health and Human Services Secretary Robert F. Kennedy Jr. may pursue banning prescription drug advertisements on television. But can he? Probably not. During President Trump’s first term in office, his administration tried to require disclosure of list prices in pharmaceutical commercials. This was shot down by a federal court judge. Attempts now at a (partial) ban are unlikely to come to fruition. Nonetheless, raising the issue has sparked a discussion around the pros and cons of direct-to-consumer drug advertising.

In an interview prior to his confirmation as secretary of HHS, Kennedy said it was time to put an end to drug advertising on television. Kennedy decried what he deemed to be the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Govt Agencies, HHS, Pharma, Pharma / Biotech
HHS layoffs: 8 things to know
‘It Will Set Us Back Multiple Decades’: Why Public Health Experts Are Panicking About the HHS Overhaul
Which jobs were cut at CDC? Here’s a list.
KFF Health News' 'What the Health?': American Health Gets a Pink Slip
RFK Jr. Ends Public Comment On HHS Policies, Conflicts With Promised Transparency

Share This Article